U.S. markets open in 6 hours 27 minutes
  • S&P Futures

    4,246.50
    +10.25 (+0.24%)
     
  • Dow Futures

    33,953.00
    +118.00 (+0.35%)
     
  • Nasdaq Futures

    14,296.75
    +38.50 (+0.27%)
     
  • Russell 2000 Futures

    2,299.90
    +7.40 (+0.32%)
     
  • Crude Oil

    73.08
    +0.02 (+0.03%)
     
  • Gold

    1,782.70
    +5.30 (+0.30%)
     
  • Silver

    25.97
    +0.11 (+0.44%)
     
  • EUR/USD

    1.1932
    -0.0011 (-0.10%)
     
  • 10-Yr Bond

    1.4720
    0.0000 (0.00%)
     
  • Vix

    16.66
    -1.23 (-6.88%)
     
  • GBP/USD

    1.3957
    +0.0010 (+0.07%)
     
  • USD/JPY

    110.8800
    +0.2450 (+0.22%)
     
  • BTC-USD

    33,940.21
    +1,165.72 (+3.56%)
     
  • CMC Crypto 200

    814.28
    +19.95 (+2.51%)
     
  • FTSE 100

    7,090.01
    0.00 (0.00%)
     
  • Nikkei 225

    28,874.89
    -9.24 (-0.03%)
     

Why AbCellera Stock Crumbled Despite In-Line Royalties For Covid Drug

·2 min read
Why AbCellera Stock Crumbled Despite In-Line Royalties For Covid Drug
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

AbCellera stock tumbled Friday, despite in-line royalties for its Lilly-partnered Covid drug. Here's why the stock toppled.